|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.05 EUR | +2.96% |
|
+2.32% | +17.41% |
| Apr. 18 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
| Mar. 07 | Van Lanschot Kempen Plans Early Redemption of EUR100 Million Notes | MT |
Van Lanschot Kempen NV reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net interest income was EUR 196.81 million compared to EUR 151.62 million a year ago. Net income was EUR 125.2 million compared to EUR 84.16 million a year ago.
Basic earnings per share from continuing operations was EUR 2.82 compared to EUR 1.9 a year ago. Diluted earnings per share from continuing operations was EUR 2.78 compared to EUR 1.82 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +17.41% | 1.49B | |
| +4.75% | 8.74B | |
| +13.83% | 3.48B | |
| -36.31% | 2.96B | |
| +13.29% | 2.52B | |
| +14.51% | 2.39B | |
| +42.63% | 2.17B | |
| +12.44% | 1.49B | |
| +9.13% | 1.42B | |
| 0.00% | 1.02B |
VAN LANSCHOT KEMPEN N.V 
